Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The respiratory centers are a collection of interconnected neuronal networks located in the medulla oblongata and pons of the brainstem that autonomously regulate the rhythm and depth of breathing (StatPearls, 2023). They consist of the dorsal respiratory group (DRG) and ventral respiratory group (VRG) in the medulla, and the pneumotaxic and apneustic centers in the pons (NIH, 2022). These centers receive sensory input from central and peripheral chemoreceptors regarding blood pH and gas concentrations, as well as mechanoreceptors in the lungs (Wikipedia, 2024). The pre-Bötzinger complex within the VRG is specifically recognized as the pacemaker for respiratory rhythm (NIH, 2022). Pharmacologically, these centers are critical sites for drug action; central nervous system depressants like opioids and benzodiazepines can cause life-threatening respiratory depression by inhibiting these neurons (PubMed, 2021). Conversely, respiratory stimulants like doxapram or caffeine are used to treat apnea by increasing the activity of these neuronal groups (PubChem, 2023). Dysregulation of these centers is implicated in various pathologies, including central sleep apnea and congenital central hypoventilation syndrome (StatPearls, 2023). Understanding the modulation of these circuits is vital for managing anesthesia, pain, and sleep-related breathing disorders.
Drugs modulate the respiratory centers by binding to specific receptors (e.g., mu-opioid receptors, GABA-A receptors) on neurons within the medulla and pons, either inhibiting or stimulating the rhythmic firing patterns that drive the diaphragm and intercostal muscles (StatPearls, 2023; PubMed, 2021).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Respiratory centers (RCC) (RCC).